Trials / Completed
CompletedNCT04855240
Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ACP-044 for Acute Postoperative Pain Following Orthopedic Surgery (Bunionectomy)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 239 (actual)
- Sponsor
- ACADIA Pharmaceuticals Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACP-044 Dose A | Oral dose of ACP-044 Dose A |
| DRUG | ACP-044 Dose B | Oral dose of ACP-044 Dose B |
| DRUG | Placebo | Oral dose of placebo |
Timeline
- Start date
- 2021-03-29
- Primary completion
- 2022-02-11
- Completion
- 2022-03-14
- First posted
- 2021-04-22
- Last updated
- 2023-05-03
- Results posted
- 2023-05-03
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04855240. Inclusion in this directory is not an endorsement.